24 related articles for article (PubMed ID: 29213105)
1. Predictive Value of Preoperative Prostate Health Index and Serum Testosterone Testing for Biochemical Recurrence after Radical Prostatectomy for Non-Metastatic Prostate Cancer.
Zhang C; Zhang Y; Niu N; Fu G
Arch Esp Urol; 2023 Dec; 76(10):787-795. PubMed ID: 38186072
[TBL] [Abstract][Full Text] [Related]
2. Comparing histology between prostate cognitive fusion targeted biopsy and radical prostatectomy: exploring risk factors of Gleason score upgrading in Chinese patients.
Zheng T; Sun H; Tang Y; Bi K; Zeng Y; Wang J; Yan L
J Cancer Res Clin Oncol; 2023 Dec; 149(20):18029-18037. PubMed ID: 37979056
[TBL] [Abstract][Full Text] [Related]
3. Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer.
Druskin SC; Tosoian JJ; Young A; Collica S; Srivastava A; Ghabili K; Macura KJ; Carter HB; Partin AW; Sokoll LJ; Ross AE; Pavlovich CP
BJU Int; 2018 Apr; 121(4):619-626. PubMed ID: 29232037
[TBL] [Abstract][Full Text] [Related]
4. Beyond Prostate Specific Antigen: New Prostate Cancer Screening Options.
Narain TA; Sooriakumaran P
World J Mens Health; 2022 Jan; 40(1):66-73. PubMed ID: 34983086
[TBL] [Abstract][Full Text] [Related]
5. Prostate Health Index (
Yan JQ; Huang D; Huang JY; Ruan XH; Lin XL; Fang ZJ; Gao Y; Jiang HW; Wu YS; Na R; Xu DF
Asian J Androl; 2022; 24(4):406-410. PubMed ID: 34782549
[TBL] [Abstract][Full Text] [Related]
6. Preoperative prostate health index and %p2PSA as the significant biomarkers of postoperative pathological outcomes of prostate cancer in Korean males: A prospective multi-institutional study.
Park H; Lee SW; Song G; Kang TW; Jung JH; Chung HC; Kim SJ; Park JY; Shin TY; Kim JH
Investig Clin Urol; 2020 Jan; 61(1):42-50. PubMed ID: 31942462
[TBL] [Abstract][Full Text] [Related]
7. Incorporation of tissue-based genomic biomarkers into localized prostate cancer clinics.
Moschini M; Spahn M; Mattei A; Cheville J; Karnes RJ
BMC Med; 2016 Apr; 14():67. PubMed ID: 27044421
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer treatment - China's perspective.
Liu J; Dong L; Zhu Y; Dong B; Sha J; Zhu HH; Pan J; Xue W
Cancer Lett; 2022 Dec; 550():215927. PubMed ID: 36162714
[TBL] [Abstract][Full Text] [Related]
9. Prognostic accuracy of Prostate Health Index and urinary Prostate Cancer Antigen 3 in predicting pathologic features after radical prostatectomy.
Cantiello F; Russo GI; Ferro M; Cicione A; Cimino S; Favilla V; Perdonà S; Bottero D; Terracciano D; De Cobelli O; Morgia G; Damiano R
Urol Oncol; 2015 Apr; 33(4):163.e15-23. PubMed ID: 25575715
[TBL] [Abstract][Full Text] [Related]
10. PHI and PCA3 improve the prognostic performance of PRIAS and Epstein criteria in predicting insignificant prostate cancer in men eligible for active surveillance.
Cantiello F; Russo GI; Cicione A; Ferro M; Cimino S; Favilla V; Perdonà S; De Cobelli O; Magno C; Morgia G; Damiano R
World J Urol; 2016 Apr; 34(4):485-93. PubMed ID: 26194612
[TBL] [Abstract][Full Text] [Related]
11. Preoperative prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and prostate health index, predict pathologic outcomes in patients undergoing radical prostatectomy for prostate cancer.
Guazzoni G; Lazzeri M; Nava L; Lughezzani G; Larcher A; Scattoni V; Gadda GM; Bini V; Cestari A; Buffi NM; Freschi M; Rigatti P; Montorsi F
Eur Urol; 2012 Mar; 61(3):455-66. PubMed ID: 22078333
[TBL] [Abstract][Full Text] [Related]
12. Preoperative Prostate-specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer: Results from a Multicentric European Prospective Study.
Fossati N; Buffi NM; Haese A; Stephan C; Larcher A; McNicholas T; de la Taille A; Freschi M; Lughezzani G; Abrate A; Bini V; Palou Redorta J; Graefen M; Guazzoni G; Lazzeri M
Eur Urol; 2015 Jul; 68(1):132-8. PubMed ID: 25139197
[TBL] [Abstract][Full Text] [Related]
13. Prostate health index density predicts aggressive pathological outcomes after radical prostatectomy in Taiwanese patients.
Huang YP; Lin TP; Cheng WM; Wei TC; Huang IS; Fan YH; Lin CC; Huang EYH; Chung HJ; Kuo JY; Wu HHH; Lu SH; Chang YH; Lin ATL; Huang WJS
J Chin Med Assoc; 2019 Nov; 82(11):835-839. PubMed ID: 31425303
[TBL] [Abstract][Full Text] [Related]
14. Preoperative prostate health index predicts poor pathologic outcomes of radical prostatectomy in patients with biopsy-detected low-risk patients prostate cancer: results from a Chinese prospective cohort.
Tang B; Han CT; Lu XL; Wan FN; Zhang CZ; Zhu Y; Ye DW
Prostate Cancer Prostatic Dis; 2018 Apr; 21(1):64-70. PubMed ID: 29213105
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
